STUB1 and neoplasm: The PBMC-derived germline/CHIP mutations had allele frequencies in plasma that overlapped with somatic tumor mutations in plasma (range 0.175–69% for PBMC-derived mutations and 0.14–82% for somatic tumor mutations, medians 1.3 and 2.2%, respectively; Extended Data Fig. 1c).